Aurobindo, Hetero, and Vivimed Class Action Settlements in Connecticut
Aurobindo, Hetero, and Vivimed class action settlements that covered Connecticut residents — and where each one now stands.
Last checked: August 11, 2026 · By Class Action Buddy
Connecticut residents have no confirmed open class action settlements involving Aurobindo, Hetero, and Vivimed right now. The Aurobindo, Hetero, and Vivimed settlement below has closed — the claim deadline has passed and no new claims can be filed. If you are looking for something you can still claim, our list of open settlements is checked against each administrator.
Class Action Buddy fills in official claim forms from your saved profile in under 60 seconds, then prints and posts the completed claim for you. There is nothing to file against Aurobindo, Hetero, and Vivimed at the moment — see what is open now.
Closed Aurobindo, Hetero, and Vivimed Settlements for Connecticut Residents (1)
This Aurobindo, Hetero, and Vivimed settlement is no longer accepting claims. It closed on the date shown and the deadline cannot be reopened. It is listed here because the settlement and its administrator are a matter of record and people still search for it. For settlements that are open today, see our list of open settlements.
$15.2M Valsartan, Losartan and Irbesartan class action settlement
Up to TBDFile your claim for the $15.2M Valsartan, Losartan, and Irbesartan settlement. Blood pressure medication contaminated with cancer-causing substances.
About Aurobindo, Hetero, and Vivimed Class Actions in Connecticut
Before you read on: the Aurobindo, Hetero, and Vivimed settlement described below has closed. This section explains what it was about and who was covered, which is still worth knowing — but it cannot be claimed now. See settlements that are open today.
Connecticut residents affected by the $15.2 million Valsartan, Losartan and Irbesartan class action settlement involving pharmaceutical manufacturers Aurobindo, Hetero, and Vivimed should understand their specific state protections. Connecticut's Unfair Trade Practices Act (CUTPA) provides broader consumer protections than federal law, allowing residents to pursue additional damages for deceptive business practices beyond class action settlements. These companies have significant distribution networks serving Connecticut pharmacies and healthcare systems, with Aurobindo maintaining regulatory compliance facilities that serve the Northeast corridor. Connecticut residents filing class action claims benefit from the state's relatively consumer-friendly court system and shorter statute of limitations periods that can expedite proceedings. The state's Department of Consumer Protection actively monitors pharmaceutical settlements and provides resources for affected consumers. Connecticut's proximity to major pharmaceutical distribution hubs in New Jersey and New York means residents often have higher exposure to recalled medications from these manufacturers, making thorough documentation of affected prescriptions particularly important for maximizing settlement compensation.
Aurobindo, Hetero, and Vivimed Settlements in Connecticut: FAQs
What makes Connecticut residents eligible for the Aurobindo, Hetero, and Vivimed settlement?
Connecticut residents who purchased or were prescribed Valsartan, Losartan, or Irbesartan medications manufactured by Aurobindo, Hetero, or Vivimed between specific dates are eligible for the $15.2 million settlement. You must have proof of purchase or prescription records from Connecticut pharmacies. Connecticut's consumer protection laws may provide additional remedies beyond the federal settlement amount.
How does Connecticut's CUTPA law affect my Aurobindo, Hetero, and Vivimed claim?
Connecticut's Unfair Trade Practices Act (CUTPA) allows residents to seek treble damages and attorney fees for deceptive practices, potentially providing additional compensation beyond the class action settlement. CUTPA claims against Aurobindo, Hetero, and Vivimed must be filed separately from the federal settlement. Connecticut courts have historically been favorable to pharmaceutical injury claims under CUTPA provisions.
Where should Connecticut residents file their Aurobindo, Hetero, and Vivimed claims?
Connecticut residents can file settlement claims online through the official settlement administrator or mail forms to the designated claims processing center. The Connecticut Department of Consumer Protection also maintains resources and complaint procedures for pharmaceutical settlements. Claims must include Connecticut pharmacy records and prescription documentation to verify eligibility for the settlement funds.
Tips for Connecticut Residents Filing Aurobindo, Hetero, and Vivimed Claims
Connecticut residents filing Aurobindo, Hetero, and Vivimed claims should gather all prescription records from Connecticut pharmacies, including CVS, Walgreens, and independent pharmacies that dispensed affected medications. Keep detailed medical records showing any adverse effects from contaminated blood pressure medications. File claims promptly as Connecticut's statute of limitations can be shorter than other states. Contact the Connecticut Department of Consumer Protection for additional resources and complaint procedures. Consider consulting attorneys familiar with CUTPA law for potential additional damages beyond the settlement amount. Document all out-of-pocket medical expenses related to medication switches or health monitoring required due to contaminated drugs.
File Aurobindo, Hetero, and Vivimed Claims in 60 Seconds
Class Action Buddy auto-fills your claim forms and submits them electronically. Your first claim is free.
